Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leprosy: what is being "eliminated"?

Authors: W Cairns S Smith; Christine M Smith; Ian A Cree; Ruprendra S Jadhav; Murdo Macdonald; Vijay K Edward; Linda Oskam; Stella van Beers; Paul Klatser
Journal: Int J Lepr Other Mycobact Dis Date: 2004-09

5 in total

11 in total

1. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

Authors: Annemieke Geluk; Jolien van der Ploeg; Rose O B Teles; Kees L M C Franken; Corine Prins; Jan Wouter Drijfhout; Euzenir N Sarno; Elizabeth P Sampaio; Tom H M Ottenhoff
Journal: Clin Vaccine Immunol Date: 2008-01-16

2. Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection.

Authors: G G Guerrero; J Rangel-Moreno; S Islas-Trujillo; Ó Rojas-Espinosa
Journal: Biomed Res Int Date: 2015-09-21 Impact factor: 3.411

3. The Burden of Leprosy in Cameroon: Fifteen Years into the Post-elimination Era.

Authors: Earnest Njih Tabah; Dickson Shey Nsagha; Anne-Cecile Zoung-Kanyi Bissek; Martin W Bratschi; Theophilus Ngeh Njamnshi; Gerd Plushke; Alfred Kongnyu Njamnshi
Journal: PLoS Negl Trop Dis Date: 2016-10-12

Review 4. Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?

Authors: Tazeem Bhatia; Jamie Enoch; Mishal Khan; Sophie Mathewson; David Heymann; Richard Hayes; Osman Dar
Journal: PLoS Med Date: 2019-02-04 Impact factor: 11.069

5. From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness.

Authors: Mark Jit; Kiesha Prem; Elodie Benard; Marc Brisson
Journal: Prev Med Date: 2020-12-10 Impact factor: 4.018

10. Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.

Authors: Anuj Tiwari; Steaven Dandel; Rita Djupuri; Liesbeth Mieras; Jan Hendrik Richardus
Journal: BMC Infect Dis Date: 2018-07-11 Impact factor: 3.090

Leprosy: what is being "eliminated"?

1. Trends in leprosy case detection worldwide since 1985.

2. Commentary: is it really M. leprae?

3. Leprosy research declines, but most of the basic questions remain unanswered.

Review 4. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).

5. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study.

1. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

2. Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection.

3. The Burden of Leprosy in Cameroon: Fifteen Years into the Post-elimination Era.

Review 4. Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?

5. From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness.

6. Use of short tandem repeat sequences to study Mycobacterium leprae in leprosy patients in Malawi and India.

7. The feasibility of eliminating podoconiosis.

8. Progress towards a leprosy-free country: The experience of Oman.

9. Introducing leprosy post-exposure prophylaxis into the health systems of India, Nepal and Indonesia: a case study.

10. Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.